

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 5.11361954 |
| 2 | doxorubicin metabolic process (GO:0044598) | 5.11361954 |
| 3 | daunorubicin metabolic process (GO:0044597) | 5.11361954 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 5.04605796 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 5.04605796 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.04605796 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.88954022 |
| 8 | tryptophan metabolic process (GO:0006568) | 4.78683112 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.68378126 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.68378126 |
| 11 | imidazole-containing compound metabolic process (GO:0052803) | 4.42998129 |
| 12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.35986858 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 4.34241013 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.34241013 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.31092657 |
| 16 | negative regulation of cell killing (GO:0031342) | 4.13281552 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.13281552 |
| 18 | cellular biogenic amine catabolic process (GO:0042402) | 4.04598992 |
| 19 | amine catabolic process (GO:0009310) | 4.04598992 |
| 20 | regulation of regulatory T cell differentiation (GO:0045589) | 4.00531599 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.99501206 |
| 22 | kynurenine metabolic process (GO:0070189) | 3.86574243 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.81096508 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 3.79812603 |
| 25 | indolalkylamine metabolic process (GO:0006586) | 3.72981294 |
| 26 | cytidine deamination (GO:0009972) | 3.72402963 |
| 27 | cytidine metabolic process (GO:0046087) | 3.72402963 |
| 28 | cytidine catabolic process (GO:0006216) | 3.72402963 |
| 29 | urea cycle (GO:0000050) | 3.71687773 |
| 30 | urea metabolic process (GO:0019627) | 3.71687773 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 3.70357088 |
| 32 | bile acid biosynthetic process (GO:0006699) | 3.59130587 |
| 33 | * NAD biosynthetic process (GO:0009435) | 3.53989694 |
| 34 | drug catabolic process (GO:0042737) | 3.53467757 |
| 35 | aldehyde catabolic process (GO:0046185) | 3.45581790 |
| 36 | regulation of activation of Janus kinase activity (GO:0010533) | 3.44042738 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.41859388 |
| 38 | tachykinin receptor signaling pathway (GO:0007217) | 3.40158528 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39148138 |
| 40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36871540 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.36430437 |
| 42 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.36221518 |
| 43 | urate metabolic process (GO:0046415) | 3.31428419 |
| 44 | drug transmembrane transport (GO:0006855) | 3.31364513 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.30643242 |
| 46 | exogenous drug catabolic process (GO:0042738) | 3.30210029 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 3.29814057 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28321344 |
| 49 | cellular glucuronidation (GO:0052695) | 3.27974924 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 3.26667930 |
| 51 | trivalent inorganic anion homeostasis (GO:0072506) | 3.24791550 |
| 52 | phosphate ion homeostasis (GO:0055062) | 3.24791550 |
| 53 | negative T cell selection (GO:0043383) | 3.22911970 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 3.20722507 |
| 55 | tyrosine metabolic process (GO:0006570) | 3.20676363 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 3.17573102 |
| 57 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.16746029 |
| 58 | cellular anion homeostasis (GO:0030002) | 3.15588901 |
| 59 | glucuronate metabolic process (GO:0019585) | 3.14102846 |
| 60 | uronic acid metabolic process (GO:0006063) | 3.14102846 |
| 61 | neutrophil activation involved in immune response (GO:0002283) | 3.14101227 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.13545580 |
| 63 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.12851499 |
| 64 | cysteine metabolic process (GO:0006534) | 3.10887610 |
| 65 | bile acid metabolic process (GO:0008206) | 3.08325210 |
| 66 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05171879 |
| 67 | phospholipid efflux (GO:0033700) | 3.00644648 |
| 68 | regulation of bile acid biosynthetic process (GO:0070857) | 2.93913145 |
| 69 | proteasome assembly (GO:0043248) | 2.93127172 |
| 70 | homocysteine metabolic process (GO:0050667) | 2.91107372 |
| 71 | adaptation of signaling pathway (GO:0023058) | 2.89974613 |
| 72 | * nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.87632747 |
| 73 | * pyridine nucleotide biosynthetic process (GO:0019363) | 2.87632747 |
| 74 | drug transport (GO:0015893) | 2.86724191 |
| 75 | regulation of T cell tolerance induction (GO:0002664) | 2.85935569 |
| 76 | proline metabolic process (GO:0006560) | 2.85359349 |
| 77 | serine family amino acid metabolic process (GO:0009069) | 2.85193979 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84662767 |
| 79 | triglyceride homeostasis (GO:0070328) | 2.84122827 |
| 80 | acylglycerol homeostasis (GO:0055090) | 2.84122827 |
| 81 | bile acid and bile salt transport (GO:0015721) | 2.83925766 |
| 82 | positive T cell selection (GO:0043368) | 2.83097214 |
| 83 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82956566 |
| 84 | protein carboxylation (GO:0018214) | 2.82956566 |
| 85 | T cell migration (GO:0072678) | 2.82498915 |
| 86 | negative thymic T cell selection (GO:0045060) | 2.81653939 |
| 87 | glycine metabolic process (GO:0006544) | 2.80071582 |
| 88 | positive regulation of digestive system process (GO:0060456) | 2.79998317 |
| 89 | positive regulation of tolerance induction (GO:0002645) | 2.79681636 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 2.79476958 |
| 91 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79357504 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 2.78611571 |
| 93 | arginine metabolic process (GO:0006525) | 2.78498832 |
| 94 | DNA deamination (GO:0045006) | 2.78243821 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 2.78039365 |
| 96 | response to nitrosative stress (GO:0051409) | 2.74700250 |
| 97 | diterpenoid biosynthetic process (GO:0016102) | 2.74275457 |
| 98 | dopamine transport (GO:0015872) | 2.73052885 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.72028799 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 2.71506741 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.71308175 |
| 102 | dendritic cell chemotaxis (GO:0002407) | 2.69259249 |
| 103 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.67948033 |
| 104 | positive regulation of B cell differentiation (GO:0045579) | 2.65779210 |
| 105 | coenzyme catabolic process (GO:0009109) | 2.64063757 |
| 106 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.61964637 |
| 107 | cellular response to interleukin-15 (GO:0071350) | 2.61929287 |
| 108 | reverse cholesterol transport (GO:0043691) | 2.60867996 |
| 109 | cofactor catabolic process (GO:0051187) | 2.60686630 |
| 110 | plasma lipoprotein particle remodeling (GO:0034369) | 2.59377688 |
| 111 | protein-lipid complex remodeling (GO:0034368) | 2.59377688 |
| 112 | macromolecular complex remodeling (GO:0034367) | 2.59377688 |
| 113 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.59289083 |
| 114 | low-density lipoprotein particle remodeling (GO:0034374) | 2.58446754 |
| 115 | regulation of tolerance induction (GO:0002643) | 2.58271587 |
| 116 | terpenoid biosynthetic process (GO:0016114) | 2.58267420 |
| 117 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57678927 |
| 118 | response to interleukin-15 (GO:0070672) | 2.57407233 |
| 119 | regulation of protein activation cascade (GO:2000257) | 2.56180471 |
| 120 | organic acid catabolic process (GO:0016054) | 2.55945736 |
| 121 | carboxylic acid catabolic process (GO:0046395) | 2.55945736 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.55885701 |
| 123 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.55157780 |
| 124 | regulation of germinal center formation (GO:0002634) | 2.55004776 |
| 125 | type I interferon signaling pathway (GO:0060337) | 2.54444887 |
| 126 | cellular response to type I interferon (GO:0071357) | 2.54444887 |
| 127 | lysine metabolic process (GO:0006553) | 2.53843931 |
| 128 | lysine catabolic process (GO:0006554) | 2.53843931 |
| 129 | regulation of fibrinolysis (GO:0051917) | 2.53834443 |
| 130 | detection of bacterium (GO:0016045) | 2.53500242 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.53373091 |
| 132 | leukocyte aggregation (GO:0070486) | 2.52956543 |
| 133 | tolerance induction (GO:0002507) | 2.51469522 |
| 134 | sulfur amino acid catabolic process (GO:0000098) | 2.49586635 |
| 135 | response to type I interferon (GO:0034340) | 2.49361864 |
| 136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.49187158 |
| 137 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.49187158 |
| 138 | activated T cell proliferation (GO:0050798) | 2.49147362 |
| 139 | drug metabolic process (GO:0017144) | 2.48129929 |
| 140 | branched-chain amino acid catabolic process (GO:0009083) | 2.46903541 |
| 141 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.46831973 |
| 142 | complement activation, alternative pathway (GO:0006957) | 2.46706675 |
| 143 | detection of external biotic stimulus (GO:0098581) | 2.45908414 |
| 144 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.45813254 |
| 145 | nucleotide transmembrane transport (GO:1901679) | 2.45532643 |
| 146 | positive thymic T cell selection (GO:0045059) | 2.45049671 |
| 147 | dendritic cell migration (GO:0036336) | 2.43065432 |
| 148 | positive regulation of granulocyte differentiation (GO:0030854) | 2.42674738 |
| 149 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.42565166 |
| 150 | carnitine metabolic process (GO:0009437) | 2.41414468 |
| 151 | T cell selection (GO:0045058) | 2.41338373 |
| 152 | detection of molecule of bacterial origin (GO:0032490) | 2.41284441 |
| 153 | valine metabolic process (GO:0006573) | 2.41136197 |
| 154 | regulation of hexokinase activity (GO:1903299) | 2.40797584 |
| 155 | regulation of glucokinase activity (GO:0033131) | 2.40797584 |
| 156 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.40549353 |
| 157 | neutrophil activation (GO:0042119) | 2.39922677 |
| 158 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.38749014 |
| 159 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.35757565 |
| 160 | T cell costimulation (GO:0031295) | 2.35059298 |
| 161 | regulation of B cell differentiation (GO:0045577) | 2.34738163 |
| 162 | immunoglobulin mediated immune response (GO:0016064) | 2.34631903 |
| 163 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34472337 |
| 164 | negative regulation of T cell apoptotic process (GO:0070233) | 2.34205214 |
| 165 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.33948590 |
| 166 | lymphocyte costimulation (GO:0031294) | 2.31748839 |
| 167 | myeloid cell activation involved in immune response (GO:0002275) | 2.31329063 |
| 168 | regulation of memory T cell differentiation (GO:0043380) | 2.31153429 |
| 169 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.31066603 |
| 170 | actin nucleation (GO:0045010) | 2.30854804 |
| 171 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.30683601 |
| 172 | negative regulation of T cell mediated immunity (GO:0002710) | 2.30410867 |
| 173 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.29793644 |
| 174 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.29793644 |
| 175 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.28132989 |
| 176 | regulation of calcium-mediated signaling (GO:0050848) | 2.27616186 |
| 177 | granulocyte activation (GO:0036230) | 2.26835098 |
| 178 | T cell receptor signaling pathway (GO:0050852) | 2.26822624 |
| 179 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.26364623 |
| 180 | leukocyte degranulation (GO:0043299) | 2.26271724 |
| 181 | lymphocyte chemotaxis (GO:0048247) | 2.26267364 |
| 182 | positive regulation of defense response to virus by host (GO:0002230) | 2.24599278 |
| 183 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.23907927 |
| 184 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.22888809 |
| 185 | mast cell activation (GO:0045576) | 2.22881695 |
| 186 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.22121822 |
| 187 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.19304040 |
| 188 | regulation of antigen processing and presentation (GO:0002577) | 2.17033820 |
| 189 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.16694302 |
| 190 | chemokine-mediated signaling pathway (GO:0070098) | 2.15773863 |
| 191 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.14676701 |
| 192 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.14486877 |
| 193 | regulation of cell killing (GO:0031341) | 2.14250826 |
| 194 | negative regulation of protein autophosphorylation (GO:0031953) | 2.13720019 |
| 195 | response to interferon-beta (GO:0035456) | 2.13662987 |
| 196 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.12764989 |
| 197 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.12336170 |
| 198 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.12336170 |
| 199 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.11256507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.36501147 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.11355229 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.11195714 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.87338409 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.66734462 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.51654459 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.29075161 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.25905846 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.23267400 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.06979653 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.96449227 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78033869 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56427598 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56094986 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.48048176 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.41836646 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.35590553 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31222233 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29874424 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.28074397 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.25409908 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.22666595 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.15800741 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14578238 |
| 25 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.10695335 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10174036 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.10001032 |
| 28 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.09355584 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.98512661 |
| 30 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.92028643 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.91074310 |
| 32 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.90112505 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.88063333 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.87180296 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77265688 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.77043355 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.74124937 |
| 38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.72213195 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71885446 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.69173423 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.68666303 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67988184 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64994164 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56537690 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56488886 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55284292 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.54411061 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.54362861 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53844590 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48493097 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47521845 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46814482 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46119577 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44228327 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43113840 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41021640 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39200268 |
| 58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39002663 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35995970 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35909995 |
| 61 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35367426 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33618845 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32299040 |
| 64 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.32261482 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.29063238 |
| 66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26381521 |
| 67 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25811837 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24987332 |
| 69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24900485 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.22783874 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.22705196 |
| 72 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22152796 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.20850750 |
| 74 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.19466129 |
| 75 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17266632 |
| 76 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16743376 |
| 77 | MYB_26560356_Chip-Seq_TH1_Human | 1.16501972 |
| 78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15950415 |
| 79 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.15139200 |
| 80 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14861118 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14344058 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13574760 |
| 83 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13315089 |
| 84 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13308814 |
| 85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12458956 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12369754 |
| 87 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12065886 |
| 88 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.11477160 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10599580 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10371508 |
| 91 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10344393 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10215453 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10025097 |
| 94 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.09782104 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08919962 |
| 96 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.07902409 |
| 97 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07060914 |
| 98 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.05542663 |
| 99 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05405812 |
| 100 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.05325454 |
| 101 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04196828 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04090183 |
| 103 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02492371 |
| 104 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.02135906 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02073046 |
| 106 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01892884 |
| 107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01798311 |
| 108 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.01539016 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01486134 |
| 110 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01246219 |
| 111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00922715 |
| 112 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00635452 |
| 113 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00632063 |
| 114 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.00319510 |
| 115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99491685 |
| 116 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98783001 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98166015 |
| 118 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.97721541 |
| 119 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96023849 |
| 120 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.95601694 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95351161 |
| 122 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94784960 |
| 123 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93993466 |
| 124 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93779834 |
| 125 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93742867 |
| 126 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92496614 |
| 127 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91841951 |
| 128 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91172809 |
| 129 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91172809 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90917252 |
| 131 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.90903458 |
| 132 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90860913 |
| 133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90388974 |
| 134 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89964219 |
| 135 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.89415939 |
| 136 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88540714 |
| 137 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88531539 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87796625 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87776211 |
| 140 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.87678039 |
| 141 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.87444329 |
| 142 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87360420 |
| 143 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86566406 |
| 144 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86215495 |
| 145 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85885342 |
| 146 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.84875073 |
| 147 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.83946568 |
| 148 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.83946568 |
| 149 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82718391 |
| 150 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81063570 |
| 151 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80933739 |
| 152 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80843145 |
| 153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79437974 |
| 154 | P300_19829295_ChIP-Seq_ESCs_Human | 0.79124300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.23029563 |
| 2 | MP0005360_urolithiasis | 4.61063643 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.20397012 |
| 4 | MP0005365_abnormal_bile_salt | 3.74987627 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.52574275 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.26356325 |
| 7 | MP0004019_abnormal_vitamin_homeostasis | 2.84209674 |
| 8 | MP0009697_abnormal_copulation | 2.60476795 |
| 9 | MP0003195_calcinosis | 2.51622050 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.49979932 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.25755579 |
| 12 | MP0005332_abnormal_amino_acid | 2.25513235 |
| 13 | MP0003252_abnormal_bile_duct | 2.16320591 |
| 14 | MP0001764_abnormal_homeostasis | 2.13549932 |
| 15 | MP0003186_abnormal_redox_activity | 1.94493256 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 1.87893096 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.85852129 |
| 18 | MP0006292_abnormal_olfactory_placode | 1.84802641 |
| 19 | MP0001501_abnormal_sleep_pattern | 1.81134527 |
| 20 | MP0002420_abnormal_adaptive_immunity | 1.79848179 |
| 21 | MP0001835_abnormal_antigen_presentation | 1.76894143 |
| 22 | MP0005647_abnormal_sex_gland | 1.76815690 |
| 23 | MP0005451_abnormal_body_composition | 1.76371196 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 1.74623601 |
| 25 | MP0003878_abnormal_ear_physiology | 1.74623601 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.74149758 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.66347072 |
| 28 | MP0009764_decreased_sensitivity_to | 1.63678829 |
| 29 | MP0008057_abnormal_DNA_replication | 1.58346115 |
| 30 | MP0000566_synostosis | 1.58149111 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.57797870 |
| 32 | MP0003868_abnormal_feces_composition | 1.55960322 |
| 33 | MP0003866_abnormal_defecation | 1.52945237 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.52880280 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.51633959 |
| 36 | MP0009840_abnormal_foam_cell | 1.50726286 |
| 37 | MP0009785_altered_susceptibility_to | 1.49165317 |
| 38 | MP0003724_increased_susceptibility_to | 1.47087975 |
| 39 | MP0002405_respiratory_system_inflammati | 1.44301979 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.44048677 |
| 41 | MP0002933_joint_inflammation | 1.43752979 |
| 42 | MP0009333_abnormal_splenocyte_physiolog | 1.39749618 |
| 43 | MP0002132_abnormal_respiratory_system | 1.38446849 |
| 44 | MP0002277_abnormal_respiratory_mucosa | 1.38097662 |
| 45 | MP0002693_abnormal_pancreas_physiology | 1.37777203 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.37235477 |
| 47 | MP0003941_abnormal_skin_development | 1.37086107 |
| 48 | MP0004381_abnormal_hair_follicle | 1.33142136 |
| 49 | MP0003303_peritoneal_inflammation | 1.31799897 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.31614104 |
| 51 | MP0003045_fibrosis | 1.30841381 |
| 52 | MP0000716_abnormal_immune_system | 1.30794104 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.29546543 |
| 54 | MP0003011_delayed_dark_adaptation | 1.27120692 |
| 55 | MP0000609_abnormal_liver_physiology | 1.25301724 |
| 56 | MP0004782_abnormal_surfactant_physiolog | 1.25014103 |
| 57 | MP0005408_hypopigmentation | 1.24667976 |
| 58 | MP0003718_maternal_effect | 1.24363021 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.23671603 |
| 60 | MP0006054_spinal_hemorrhage | 1.23392300 |
| 61 | MP0002398_abnormal_bone_marrow | 1.20636857 |
| 62 | MP0008058_abnormal_DNA_repair | 1.20133866 |
| 63 | MP0000685_abnormal_immune_system | 1.18473292 |
| 64 | MP0008469_abnormal_protein_level | 1.18340802 |
| 65 | MP0005379_endocrine/exocrine_gland_phen | 1.18328717 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.18066649 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 1.17586499 |
| 68 | MP0004510_myositis | 1.16036631 |
| 69 | MP0003075_altered_response_to | 1.15557900 |
| 70 | MP0002160_abnormal_reproductive_system | 1.14875428 |
| 71 | MP0005671_abnormal_response_to | 1.13733527 |
| 72 | MP0005083_abnormal_biliary_tract | 1.13610079 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.12774189 |
| 74 | MP0005646_abnormal_pituitary_gland | 1.11974955 |
| 75 | MP0001873_stomach_inflammation | 1.10453023 |
| 76 | MP0001765_abnormal_ion_homeostasis | 1.10380916 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.08959905 |
| 78 | MP0005310_abnormal_salivary_gland | 1.08146147 |
| 79 | MP0001851_eye_inflammation | 1.07898218 |
| 80 | MP0003300_gastrointestinal_ulcer | 1.07857786 |
| 81 | MP0002009_preneoplasia | 1.04724744 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 1.04244844 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.03578413 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.02597946 |
| 85 | MP0003786_premature_aging | 1.02489323 |
| 86 | MP0005535_abnormal_body_temperature | 1.02007883 |
| 87 | MP0002254_reproductive_system_inflammat | 1.01787277 |
| 88 | MP0001853_heart_inflammation | 1.01577437 |
| 89 | MP0005387_immune_system_phenotype | 1.01364664 |
| 90 | MP0001790_abnormal_immune_system | 1.01364664 |
| 91 | MP0001188_hyperpigmentation | 1.01073524 |
| 92 | MP0005025_abnormal_response_to | 1.00879739 |
| 93 | MP0005464_abnormal_platelet_physiology | 1.00265388 |
| 94 | MP0002419_abnormal_innate_immunity | 0.99402572 |
| 95 | MP0005389_reproductive_system_phenotype | 0.98336083 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.98200616 |
| 97 | MP0001800_abnormal_humoral_immune | 0.98164929 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.97860361 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.97499079 |
| 100 | MP0003690_abnormal_glial_cell | 0.97481735 |
| 101 | MP0008004_abnormal_stomach_pH | 0.96226166 |
| 102 | MP0003787_abnormal_imprinting | 0.96108173 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.95498371 |
| 104 | MP0000604_amyloidosis | 0.95480044 |
| 105 | MP0003436_decreased_susceptibility_to | 0.95063153 |
| 106 | MP0005670_abnormal_white_adipose | 0.94727384 |
| 107 | MP0005174_abnormal_tail_pigmentation | 0.93843276 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.93434850 |
| 109 | MP0002006_tumorigenesis | 0.93398716 |
| 110 | MP0004043_abnormal_pH_regulation | 0.92556706 |
| 111 | MP0002722_abnormal_immune_system | 0.92383209 |
| 112 | MP0002429_abnormal_blood_cell | 0.92219657 |
| 113 | MP0005166_decreased_susceptibility_to | 0.91858114 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.91437238 |
| 115 | MP0003136_yellow_coat_color | 0.91274482 |
| 116 | MP0008872_abnormal_physiological_respon | 0.90633560 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.90467208 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.90164986 |
| 119 | MP0009763_increased_sensitivity_to | 0.89466366 |
| 120 | MP0001119_abnormal_female_reproductive | 0.88705390 |
| 121 | MP0004947_skin_inflammation | 0.88614186 |
| 122 | MP0001968_abnormal_touch/_nociception | 0.87979570 |
| 123 | MP0002723_abnormal_immune_serum | 0.87418842 |
| 124 | MP0003633_abnormal_nervous_system | 0.86804695 |
| 125 | MP0005000_abnormal_immune_tolerance | 0.85938414 |
| 126 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85257601 |
| 127 | MP0004147_increased_porphyrin_level | 0.84462969 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.83685059 |
| 129 | MP0002928_abnormal_bile_duct | 0.82922857 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.82806475 |
| 131 | MP0006082_CNS_inflammation | 0.82241084 |
| 132 | MP0002168_other_aberrant_phenotype | 0.81933528 |
| 133 | MP0000343_altered_response_to | 0.81460385 |
| 134 | MP0003693_abnormal_embryo_hatching | 0.80891631 |
| 135 | MP0001919_abnormal_reproductive_system | 0.79722051 |
| 136 | MP0008877_abnormal_DNA_methylation | 0.79680428 |
| 137 | MP0000703_abnormal_thymus_morphology | 0.78744475 |
| 138 | MP0000372_irregular_coat_pigmentation | 0.78183471 |
| 139 | MP0003879_abnormal_hair_cell | 0.77968782 |
| 140 | MP0001186_pigmentation_phenotype | 0.77376366 |
| 141 | MP0002452_abnormal_antigen_presenting | 0.77129977 |
| 142 | MP0000598_abnormal_liver_morphology | 0.75013416 |
| 143 | MP0008007_abnormal_cellular_replicative | 0.74446633 |
| 144 | MP0002396_abnormal_hematopoietic_system | 0.71735980 |
| 145 | MP0001756_abnormal_urination | 0.70430568 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.70095276 |
| 147 | MP0003763_abnormal_thymus_physiology | 0.69277774 |
| 148 | MP0006036_abnormal_mitochondrial_physio | 0.69208732 |
| 149 | MP0002638_abnormal_pupillary_reflex | 0.68731395 |
| 150 | MP0005395_other_phenotype | 0.67048646 |
| 151 | MP0009642_abnormal_blood_homeostasis | 0.66714644 |
| 152 | MP0000689_abnormal_spleen_morphology | 0.66669818 |
| 153 | MP0008260_abnormal_autophagy | 0.66182454 |
| 154 | MP0001819_abnormal_immune_cell | 0.62454944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 4.57263717 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 4.01351714 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86419940 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.77846022 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70463668 |
| 6 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.67045466 |
| 7 | Joint hemorrhage (HP:0005261) | 3.48039063 |
| 8 | Renal cortical cysts (HP:0000803) | 3.34348845 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26281538 |
| 10 | Abnormality of macrophages (HP:0004311) | 3.24729729 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.23825945 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.15825486 |
| 13 | Proximal tubulopathy (HP:0000114) | 3.15467734 |
| 14 | T lymphocytopenia (HP:0005403) | 3.12032798 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.10737759 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.09282695 |
| 17 | Hyperglycinuria (HP:0003108) | 3.05830362 |
| 18 | Abnormality of T cell number (HP:0011839) | 3.04125746 |
| 19 | Hyperglycinemia (HP:0002154) | 3.01007824 |
| 20 | Reduced antithrombin III activity (HP:0001976) | 3.00627147 |
| 21 | Hematochezia (HP:0002573) | 2.98971187 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 2.98709324 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 2.97773145 |
| 24 | Myositis (HP:0100614) | 2.94735831 |
| 25 | Parakeratosis (HP:0001036) | 2.92155390 |
| 26 | Abnormality of serum amino acid levels (HP:0003112) | 2.88147758 |
| 27 | Episodic fever (HP:0001954) | 2.79857900 |
| 28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79036947 |
| 29 | Abnormality of the renal collecting system (HP:0004742) | 2.74145579 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 2.73082500 |
| 31 | Optic neuritis (HP:0100653) | 2.73082500 |
| 32 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.71162559 |
| 33 | Duplicated collecting system (HP:0000081) | 2.70952151 |
| 34 | IgG deficiency (HP:0004315) | 2.69908930 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.69035033 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.69035033 |
| 37 | Abnormal biliary tract physiology (HP:0012439) | 2.68718409 |
| 38 | Bile duct proliferation (HP:0001408) | 2.68718409 |
| 39 | Chronic hepatic failure (HP:0100626) | 2.66999078 |
| 40 | Increased circulating renin level (HP:0000848) | 2.65122042 |
| 41 | Petechiae (HP:0000967) | 2.64870286 |
| 42 | Eczematoid dermatitis (HP:0000976) | 2.63370186 |
| 43 | Orchitis (HP:0100796) | 2.60363758 |
| 44 | Epistaxis (HP:0000421) | 2.60002489 |
| 45 | Hyperammonemia (HP:0001987) | 2.57154093 |
| 46 | Decreased circulating renin level (HP:0003351) | 2.53679884 |
| 47 | Pulmonary embolism (HP:0002204) | 2.50912263 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.50457605 |
| 49 | Vasculitis (HP:0002633) | 2.50234133 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50062346 |
| 51 | Pulmonary infiltrates (HP:0002113) | 2.49165582 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.48966977 |
| 53 | Recurrent skin infections (HP:0001581) | 2.47514935 |
| 54 | Papilledema (HP:0001085) | 2.46976025 |
| 55 | Gingival bleeding (HP:0000225) | 2.46456533 |
| 56 | Chronic diarrhea (HP:0002028) | 2.44683433 |
| 57 | Chromsome breakage (HP:0040012) | 2.44568601 |
| 58 | Fat malabsorption (HP:0002630) | 2.44280157 |
| 59 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42346071 |
| 60 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42346071 |
| 61 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42346071 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42282869 |
| 63 | Abnormality of T cells (HP:0002843) | 2.41930903 |
| 64 | Prolonged neonatal jaundice (HP:0006579) | 2.41518832 |
| 65 | Hemoptysis (HP:0002105) | 2.41166311 |
| 66 | Purpura (HP:0000979) | 2.40831380 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.39957618 |
| 68 | Enlarged kidneys (HP:0000105) | 2.38312613 |
| 69 | Gastrointestinal infarctions (HP:0005244) | 2.36033406 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35647864 |
| 71 | Recurrent bacterial skin infections (HP:0005406) | 2.35415659 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.35165022 |
| 73 | Recurrent abscess formation (HP:0002722) | 2.34639648 |
| 74 | Type I transferrin isoform profile (HP:0003642) | 2.34060489 |
| 75 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33424007 |
| 76 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33424007 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33424007 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.32356619 |
| 79 | Increased CSF protein (HP:0002922) | 2.31986513 |
| 80 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.31696905 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28572072 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.28572072 |
| 83 | Joint swelling (HP:0001386) | 2.27662708 |
| 84 | Thyroiditis (HP:0100646) | 2.24313071 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.23923600 |
| 86 | Xanthomatosis (HP:0000991) | 2.22364874 |
| 87 | Decreased central vision (HP:0007663) | 2.21898310 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.21583041 |
| 89 | Increased IgM level (HP:0003496) | 2.21194969 |
| 90 | Steatorrhea (HP:0002570) | 2.20343478 |
| 91 | Ketoacidosis (HP:0001993) | 2.20125060 |
| 92 | Metaphyseal dysplasia (HP:0100255) | 2.18281147 |
| 93 | Recurrent fungal infections (HP:0002841) | 2.17575284 |
| 94 | Deep venous thrombosis (HP:0002625) | 2.17033241 |
| 95 | Dicarboxylic aciduria (HP:0003215) | 2.15463214 |
| 96 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15463214 |
| 97 | Lethargy (HP:0001254) | 2.15436416 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 2.14512173 |
| 99 | Glycosuria (HP:0003076) | 2.14512173 |
| 100 | Abnormality of the renal cortex (HP:0011035) | 2.14506749 |
| 101 | Fair hair (HP:0002286) | 2.14240812 |
| 102 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13751537 |
| 103 | Obstructive lung disease (HP:0006536) | 2.13751537 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.13305692 |
| 105 | Erythroderma (HP:0001019) | 2.12225861 |
| 106 | Microvesicular hepatic steatosis (HP:0001414) | 2.12082184 |
| 107 | Pancreatic cysts (HP:0001737) | 2.11658365 |
| 108 | Osteomalacia (HP:0002749) | 2.11533186 |
| 109 | Abnormality of renal resorption (HP:0011038) | 2.11230936 |
| 110 | Pustule (HP:0200039) | 2.11219460 |
| 111 | Meningitis (HP:0001287) | 2.10863386 |
| 112 | Gangrene (HP:0100758) | 2.09656454 |
| 113 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07428831 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07428831 |
| 115 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07338615 |
| 116 | Alkalosis (HP:0001948) | 2.04868166 |
| 117 | Pancreatic fibrosis (HP:0100732) | 2.02940972 |
| 118 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01073449 |
| 119 | Alopecia of scalp (HP:0002293) | 2.00640789 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99777942 |
| 121 | Hyperbilirubinemia (HP:0002904) | 1.99048430 |
| 122 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.98062751 |
| 123 | Dyschromatopsia (HP:0007641) | 1.97411094 |
| 124 | Severe combined immunodeficiency (HP:0004430) | 1.96731145 |
| 125 | Cerebral edema (HP:0002181) | 1.96508924 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 1.95789783 |
| 127 | Renal tubular acidosis (HP:0001947) | 1.94905862 |
| 128 | Complement deficiency (HP:0004431) | 1.94504203 |
| 129 | True hermaphroditism (HP:0010459) | 1.94111052 |
| 130 | Delayed CNS myelination (HP:0002188) | 1.93457005 |
| 131 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.93136788 |
| 132 | Renal tubular dysfunction (HP:0000124) | 1.92193490 |
| 133 | Abnormality of iron homeostasis (HP:0011031) | 1.91329898 |
| 134 | Hypolipoproteinemia (HP:0010981) | 1.91080480 |
| 135 | Systemic lupus erythematosus (HP:0002725) | 1.90774157 |
| 136 | Metabolic acidosis (HP:0001942) | 1.90382701 |
| 137 | Chest pain (HP:0100749) | 1.89889327 |
| 138 | Mutism (HP:0002300) | 1.89379294 |
| 139 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.88811153 |
| 140 | Abnormality of alanine metabolism (HP:0010916) | 1.88811153 |
| 141 | Hyperalaninemia (HP:0003348) | 1.88811153 |
| 142 | Keratoconjunctivitis (HP:0001096) | 1.86317345 |
| 143 | Sensory axonal neuropathy (HP:0003390) | 1.85780399 |
| 144 | Abnormality of the prostate (HP:0008775) | 1.85072303 |
| 145 | Abnormality of secondary sexual hair (HP:0009888) | 1.85065104 |
| 146 | Abnormality of the axillary hair (HP:0100134) | 1.85065104 |
| 147 | Prostate neoplasm (HP:0100787) | 1.84976311 |
| 148 | Keratoconjunctivitis sicca (HP:0001097) | 1.84751748 |
| 149 | Leukocytosis (HP:0001974) | 1.84514866 |
| 150 | Ketosis (HP:0001946) | 1.84335660 |
| 151 | Hyperactive renin-angiotensin system (HP:0000841) | 1.83681869 |
| 152 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.83601662 |
| 153 | Elevated hepatic transaminases (HP:0002910) | 1.83422916 |
| 154 | Pancytopenia (HP:0001876) | 1.82460366 |
| 155 | Alveolar cell carcinoma (HP:0006519) | 1.82106899 |
| 156 | Progressive neurologic deterioration (HP:0002344) | 1.81376079 |
| 157 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81032535 |
| 158 | Cheilitis (HP:0100825) | 1.80611804 |
| 159 | Vacuolated lymphocytes (HP:0001922) | 1.80303242 |
| 160 | Ventricular fibrillation (HP:0001663) | 1.79210293 |
| 161 | Encephalitis (HP:0002383) | 1.79064167 |
| 162 | Epidermoid cyst (HP:0200040) | 1.78186469 |
| 163 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.77432485 |
| 164 | Malnutrition (HP:0004395) | 1.76419928 |
| 165 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.75848319 |
| 166 | Vascular calcification (HP:0004934) | 1.75461536 |
| 167 | Mediastinal lymphadenopathy (HP:0100721) | 1.74819836 |
| 168 | Granulocytopenia (HP:0001913) | 1.74537977 |
| 169 | Hypergonadotropic hypogonadism (HP:0000815) | 1.74417015 |
| 170 | Nausea (HP:0002018) | 1.74281575 |
| 171 | Opisthotonus (HP:0002179) | 1.74153030 |
| 172 | Tetany (HP:0001281) | 1.73942929 |
| 173 | Abnormality of macular pigmentation (HP:0008002) | 1.73851632 |
| 174 | Recurrent bronchitis (HP:0002837) | 1.73312696 |
| 175 | Birth length less than 3rd percentile (HP:0003561) | 1.73298474 |
| 176 | Spontaneous abortion (HP:0005268) | 1.73232344 |
| 177 | Arterial thrombosis (HP:0004420) | 1.73079902 |
| 178 | Lymphopenia (HP:0001888) | 1.72539128 |
| 179 | Recurrent sinusitis (HP:0011108) | 1.72298053 |
| 180 | Acute hepatic failure (HP:0006554) | 1.72267012 |
| 181 | Type 2 muscle fiber atrophy (HP:0003554) | 1.72195383 |
| 182 | Hypothermia (HP:0002045) | 1.71442789 |
| 183 | Hypoglycemic coma (HP:0001325) | 1.70802870 |
| 184 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.70279232 |
| 185 | Abnormal drinking behavior (HP:0030082) | 1.68209733 |
| 186 | Polydipsia (HP:0001959) | 1.68209733 |
| 187 | Acne (HP:0001061) | 1.67455814 |
| 188 | Abnormality of eosinophils (HP:0001879) | 1.66953365 |
| 189 | Hypoalbuminemia (HP:0003073) | 1.66006504 |
| 190 | Abnormal albumin level (HP:0012116) | 1.66006504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.88567601 |
| 2 | ZAK | 3.39007814 |
| 3 | IRAK4 | 3.30877597 |
| 4 | FRK | 3.07867509 |
| 5 | STK16 | 2.98826989 |
| 6 | SIK3 | 2.89195567 |
| 7 | MAP3K14 | 2.72468250 |
| 8 | PLK4 | 2.34748421 |
| 9 | CAMKK2 | 2.19794544 |
| 10 | FES | 2.07320311 |
| 11 | RIPK4 | 2.03281465 |
| 12 | TXK | 1.98728999 |
| 13 | VRK1 | 1.93463992 |
| 14 | IRAK2 | 1.80074001 |
| 15 | IRAK1 | 1.75874489 |
| 16 | ZAP70 | 1.73878039 |
| 17 | GRK6 | 1.73005306 |
| 18 | ITK | 1.71458428 |
| 19 | EPHA2 | 1.67053650 |
| 20 | BMPR1B | 1.66759840 |
| 21 | CASK | 1.65815426 |
| 22 | BCKDK | 1.60609839 |
| 23 | STK38L | 1.55292925 |
| 24 | JAK1 | 1.54648356 |
| 25 | CSK | 1.50707937 |
| 26 | ADRBK2 | 1.50670553 |
| 27 | SRPK1 | 1.48825121 |
| 28 | CSF1R | 1.43533230 |
| 29 | PINK1 | 1.41145209 |
| 30 | TNIK | 1.38035107 |
| 31 | TAOK3 | 1.35767247 |
| 32 | EIF2AK2 | 1.35633727 |
| 33 | IKBKB | 1.28847050 |
| 34 | BMPR2 | 1.28724727 |
| 35 | WEE1 | 1.27899427 |
| 36 | TYK2 | 1.27822557 |
| 37 | BUB1 | 1.25558814 |
| 38 | PBK | 1.24343221 |
| 39 | LCK | 1.23903587 |
| 40 | EIF2AK3 | 1.23267454 |
| 41 | PIK3CG | 1.21420470 |
| 42 | TEC | 1.21291726 |
| 43 | PTK2B | 1.20739357 |
| 44 | AKT3 | 1.19744894 |
| 45 | KDR | 1.18854982 |
| 46 | NME2 | 1.18510679 |
| 47 | IKBKE | 1.18482006 |
| 48 | DAPK2 | 1.18390764 |
| 49 | NLK | 1.15118504 |
| 50 | MAP3K13 | 1.14821331 |
| 51 | PRKCQ | 1.12820996 |
| 52 | NUAK1 | 1.08590497 |
| 53 | INSRR | 1.02978378 |
| 54 | NEK6 | 1.02302476 |
| 55 | MAP3K12 | 1.01764138 |
| 56 | ACVR1B | 1.00216635 |
| 57 | HCK | 0.95417710 |
| 58 | MATK | 0.94718749 |
| 59 | FGR | 0.93953341 |
| 60 | MYLK | 0.92048207 |
| 61 | GRK1 | 0.91102531 |
| 62 | MAPKAPK3 | 0.91054352 |
| 63 | NEK9 | 0.91037574 |
| 64 | SIK1 | 0.90593095 |
| 65 | TTK | 0.89001264 |
| 66 | GRK7 | 0.88034366 |
| 67 | JAK3 | 0.86971467 |
| 68 | JAK2 | 0.85171751 |
| 69 | CDK3 | 0.84749745 |
| 70 | CDK8 | 0.83820805 |
| 71 | YES1 | 0.83210568 |
| 72 | MAP3K11 | 0.81998791 |
| 73 | WNK3 | 0.81621414 |
| 74 | MAP3K3 | 0.81371433 |
| 75 | MST4 | 0.80998133 |
| 76 | ERN1 | 0.80745278 |
| 77 | PDK1 | 0.80580162 |
| 78 | TIE1 | 0.79934585 |
| 79 | OXSR1 | 0.79764578 |
| 80 | PRPF4B | 0.79590064 |
| 81 | MAPK15 | 0.79247773 |
| 82 | CAMKK1 | 0.79097932 |
| 83 | FER | 0.78653094 |
| 84 | BLK | 0.78592996 |
| 85 | MAP3K1 | 0.78365823 |
| 86 | GRK5 | 0.72372178 |
| 87 | TSSK6 | 0.72274956 |
| 88 | EIF2AK1 | 0.70797217 |
| 89 | PAK3 | 0.70132244 |
| 90 | EPHA3 | 0.69744067 |
| 91 | ADRBK1 | 0.69516565 |
| 92 | ATR | 0.68049836 |
| 93 | BTK | 0.67426205 |
| 94 | MAP3K4 | 0.66808665 |
| 95 | CHUK | 0.66364606 |
| 96 | FGFR3 | 0.65952072 |
| 97 | PLK3 | 0.65515939 |
| 98 | SGK2 | 0.64694052 |
| 99 | MKNK2 | 0.64214012 |
| 100 | PRKCH | 0.63108519 |
| 101 | TRPM7 | 0.62404182 |
| 102 | ERBB3 | 0.62049472 |
| 103 | TNK2 | 0.61605714 |
| 104 | MARK3 | 0.61327249 |
| 105 | EPHB1 | 0.60405076 |
| 106 | KIT | 0.59921528 |
| 107 | LYN | 0.59878641 |
| 108 | FGFR4 | 0.59835952 |
| 109 | MUSK | 0.59706839 |
| 110 | PIM2 | 0.58780820 |
| 111 | TGFBR2 | 0.58750792 |
| 112 | MKNK1 | 0.57916747 |
| 113 | CDK7 | 0.57726594 |
| 114 | TAOK2 | 0.57600725 |
| 115 | BRSK2 | 0.57364824 |
| 116 | STK39 | 0.56560343 |
| 117 | RPS6KA5 | 0.56485029 |
| 118 | MAP2K3 | 0.55877796 |
| 119 | MAPK12 | 0.55578769 |
| 120 | NEK1 | 0.55521714 |
| 121 | TBK1 | 0.51237760 |
| 122 | SIK2 | 0.50825200 |
| 123 | MAP3K9 | 0.50696883 |
| 124 | LATS1 | 0.50094432 |
| 125 | IGF1R | 0.49862721 |
| 126 | ABL2 | 0.49322233 |
| 127 | MAPK7 | 0.49240477 |
| 128 | CSNK2A1 | 0.48747012 |
| 129 | PIM1 | 0.48615698 |
| 130 | MAP4K1 | 0.48281187 |
| 131 | PRKCE | 0.47427580 |
| 132 | PRKD2 | 0.47358823 |
| 133 | MAP3K6 | 0.47283011 |
| 134 | STK10 | 0.47021897 |
| 135 | CLK1 | 0.46471032 |
| 136 | PRKCD | 0.46322038 |
| 137 | MST1R | 0.45912639 |
| 138 | MAP2K6 | 0.45423972 |
| 139 | PRKAA2 | 0.44411746 |
| 140 | PLK1 | 0.44278294 |
| 141 | PHKG1 | 0.43697268 |
| 142 | PHKG2 | 0.43697268 |
| 143 | MAP3K2 | 0.43008024 |
| 144 | CHEK2 | 0.41872387 |
| 145 | MAPK11 | 0.41626282 |
| 146 | HIPK2 | 0.41093577 |
| 147 | PRKCA | 0.40571540 |
| 148 | ABL1 | 0.40116918 |
| 149 | MAPK4 | 0.40033250 |
| 150 | SYK | 0.39974741 |
| 151 | PRKCG | 0.39601419 |
| 152 | FLT3 | 0.39400407 |
| 153 | DYRK3 | 0.39012591 |
| 154 | TAOK1 | 0.37290142 |
| 155 | MAPK13 | 0.36182369 |
| 156 | FYN | 0.35952861 |
| 157 | MAP2K7 | 0.35828175 |
| 158 | CAMK1 | 0.35193685 |
| 159 | MOS | 0.34826502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.01139622 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76280875 |
| 3 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.54039797 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.50821669 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45811504 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.28182053 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23887865 |
| 8 | Peroxisome_Homo sapiens_hsa04146 | 2.20526012 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13000599 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.12594363 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.12345927 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.10906862 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06281819 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 2.03217547 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.00183005 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.98207002 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95300036 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87029154 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85521871 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.78155577 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74342361 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.74172498 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68536739 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.65634242 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65211173 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64260145 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63851629 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62609215 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62390968 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.61241581 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.61149753 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60728854 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.60301781 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59207272 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.52666726 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51558986 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.46802213 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.46234129 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.45634489 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45630070 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.44974657 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44346815 |
| 43 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.40123828 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37096617 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.36914502 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.34560190 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33900344 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.32171577 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31335463 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27209625 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 1.27094885 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26250873 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24072238 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22996901 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22247652 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22217720 |
| 57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21650110 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 1.19947241 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19944276 |
| 60 | DNA replication_Homo sapiens_hsa03030 | 1.16030276 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14541856 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13889181 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13831797 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08390391 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08039120 |
| 66 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03545816 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02191831 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 1.00838546 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98608612 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98501566 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.97392436 |
| 72 | Mismatch repair_Homo sapiens_hsa03430 | 0.94662139 |
| 73 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93313445 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.93026559 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.91987130 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91915738 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91812438 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.89724824 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.89392882 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88737376 |
| 81 | Ribosome_Homo sapiens_hsa03010 | 0.88618091 |
| 82 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.88325886 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.87462565 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87028457 |
| 85 | Malaria_Homo sapiens_hsa05144 | 0.85422465 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85197698 |
| 87 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84742883 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83983668 |
| 89 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.79712598 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79580696 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79149121 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75975686 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.74754530 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74296541 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72177865 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71988195 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71395641 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.71028141 |
| 99 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70718610 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.70598941 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.69661810 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69360237 |
| 103 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67104032 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64934372 |
| 105 | Influenza A_Homo sapiens_hsa05164 | 0.64693445 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.64673081 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64275155 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.64179129 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.63569113 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62592491 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62549366 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61164936 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60514585 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59875078 |
| 115 | Base excision repair_Homo sapiens_hsa03410 | 0.59389745 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58820757 |
| 117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58697842 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58528785 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58378828 |
| 120 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57020848 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56531717 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56074211 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56042713 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.55255071 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55073303 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54739916 |
| 127 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.54045453 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49885213 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47911537 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47620558 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46957991 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.46333761 |
| 133 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45172641 |
| 134 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44913319 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.44741940 |
| 136 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44562757 |
| 137 | RNA degradation_Homo sapiens_hsa03018 | 0.43579080 |
| 138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42703851 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42225493 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39472610 |
| 141 | Lysine degradation_Homo sapiens_hsa00310 | 0.37867191 |
| 142 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37622674 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.37603058 |
| 144 | Allograft rejection_Homo sapiens_hsa05330 | 0.36815315 |
| 145 | Carbon metabolism_Homo sapiens_hsa01200 | 0.36106556 |
| 146 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34845448 |
| 147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34521877 |
| 148 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.34329424 |
| 149 | Measles_Homo sapiens_hsa05162 | 0.32133562 |
| 150 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32030510 |

